Interacting Drugs |
Paclitaxel (nanoparticle albumin bound) vs CYP2C8 Inducers (Highly Effective) |
Security Level |
 |
Mechanism |
CYP2C8 Inducers (Highly Effective): May increase the metabolism of CYP2C8 Substrates (High risk). |
Management |
Monitor therapy |
Paclitaxel (nanoparticle albumin bound) vs CYP2C8 Inducers (Highly Effective)
Post Review about Paclitaxel (nanoparticle albumin bound) vs CYP2C8 Inducers (Highly Effective) Click here to cancel reply.
Other Interactions of Paclitaxel (nanoparticle albumin bound)
Other Interactions of CYP2C8 Inducers (Highly Effective)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.